Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 11, 2012 - Issue 1
Submit an article Journal homepage
261
Views
6
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

Safety and tolerability of extended-release niacin with laropiprant

Rahul YadavUniversity of Manchester, School of Biomedicine, Cardiovascular Research Group, Core Technology Facility, 46, Grafton Street, Manchester, M13 9NT, UK
, MRCP,
See KwokUniversity of Manchester, School of Biomedicine, Cardiovascular Research group, Core Technology Facility, 46, Grafton street, Manchester, M13 9NT, UK
, MD,
Basil J. AmmoriDepartment of Surgery, Salford Royal NHS Foundation Trust, Stott Lane, Salford, M6 8HD, UK
,
Basil IssaUniversity Hospital of South Manchester NHS Foundation Trust, Department of Diabetes and Endocrinologist, Southmoor Road, Manchester, M23 9LT, UK
, MD &
Handrean SoranCentral Manchester University Hospitals Foundation Trust, University Department of Medicine, Manchester, UK+0044 0 161 276 4443/4066; +0044 0 161 276 3630; [email protected]; [email protected]
, MSc FRCP MD
Pages 151-159 | Published online: 01 Dec 2011

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Avishay Elis. (2012) Should HDL cholesterol levels be the primary target of cardiovascular disease risk assessment and therapy?. Expert Review of Cardiovascular Therapy 10:6, pages 675-677.
Read now
Rahul Yadav, Michael France, Naveed Younis, Salam Hama, Basil J Ammori, See Kwok & Handrean Soran. (2012) Extended-release niacin with laropiprant: a review on efficacy, clinical effectiveness and safety. Expert Opinion on Pharmacotherapy 13:9, pages 1345-1362.
Read now

Articles from other publishers (4)

Zohaib Iqbal, Jan Hoong Ho, Safwaan Adam, Michael France, Akheel Syed, Dermot Neely, Alan Rees, Rani Khatib, Jaimini Cegla, Christopher Byrne, Nadeem Qureshi, Nigel Capps, Gordon Ferns, Jules Payne, Jonathan Schofield, Kirsty Nicholson, Dev Datta, Alison Pottle, Julian Halcox, Andrew Krentz, Paul Durrington & Handrean Soran. (2020) Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK. Atherosclerosis 313, pages 126-136.
Crossref
Ulrich Julius. (2015) Niacin as antidyslipidemic drug. Canadian Journal of Physiology and Pharmacology 93:12, pages 1043-1054.
Crossref
U. Julius & S. Fischer. (2013) Nicotinic acid as a lipid-modifying drug – A review. Atherosclerosis Supplements 14:1, pages 7-13.
Crossref
Handrean Soran, Salam Hama, Rahul Yadav & Paul N. Durrington. (2012) HDL functionality. Current Opinion in Lipidology 23:4, pages 353-366.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.